Assessment of the Efficacy of Verapamil to Prevent Radial Artery Occlusion during Cardiac Catheterization Procedures: A Randomized Study Comparing Verapamil VS Placebo
El Etriby, S., Salama, A., Sharaf, S., Tamara, A. (2022). Assessment of the Efficacy of Verapamil to Prevent Radial Artery Occlusion during Cardiac Catheterization Procedures: A Randomized Study Comparing Verapamil VS Placebo. EKB Journal Management System, 89(2), 6743-6749. doi: 10.21608/ejhm.2022.270770
Shehab Adel El Etriby; Ahmed Yehia Ramadan Salama; Sherif Mohamed Kamel Sharaf; Ahmed Fathy Tamara. "Assessment of the Efficacy of Verapamil to Prevent Radial Artery Occlusion during Cardiac Catheterization Procedures: A Randomized Study Comparing Verapamil VS Placebo". EKB Journal Management System, 89, 2, 2022, 6743-6749. doi: 10.21608/ejhm.2022.270770
El Etriby, S., Salama, A., Sharaf, S., Tamara, A. (2022). 'Assessment of the Efficacy of Verapamil to Prevent Radial Artery Occlusion during Cardiac Catheterization Procedures: A Randomized Study Comparing Verapamil VS Placebo', EKB Journal Management System, 89(2), pp. 6743-6749. doi: 10.21608/ejhm.2022.270770
El Etriby, S., Salama, A., Sharaf, S., Tamara, A. Assessment of the Efficacy of Verapamil to Prevent Radial Artery Occlusion during Cardiac Catheterization Procedures: A Randomized Study Comparing Verapamil VS Placebo. EKB Journal Management System, 2022; 89(2): 6743-6749. doi: 10.21608/ejhm.2022.270770

Assessment of the Efficacy of Verapamil to Prevent Radial Artery Occlusion during Cardiac Catheterization Procedures: A Randomized Study Comparing Verapamil VS Placebo

The Egyptian Journal of Hospital Medicine
Article 100, Volume 89, Issue 2, October 2022, Page 6743-6749  XML PDF (519.7 K)
Document Type: Original Article
DOI: 10.21608/ejhm.2022.270770
View on SCiNiTO View on SCiNiTO
Authors
Shehab Adel El Etriby email ; Ahmed Yehia Ramadan Salama; Sherif Mohamed Kamel Sharaf; Ahmed Fathy Tamara
Department of cardiology, Faculty of Medicine, Ain Shams University
Abstract
Background: During the transradial approach, radial artery spasm is common complication that might make the patient uncomfortable or make it impossible to complete the treatment for patients over 40years old.
Objective: It was to compare the conventional spasmolytic drug (verapamil) with a placebo.
Patients and Methods: We conducted a randomised, double-blind, prospective study at two-center. After being randomly assigned to receive 2.5mg verapamil after sheath insertion and another 2.5mg before sheath removal at the end of the cardiac procedure (each diluted in 5ml normal saline) or placebo 5ml of normal saline after sheath insertion and before removal, 150 patients (75 in each group) who underwent a transradial cardiac catheterization were subsequently included.
Results: The rate of radial occlusion was nearly the same in both groups (10% vs. 15% in verapamil and placebo treated patients, respectively) at the 24-hour follow-up evaluation of the radial artery patency by pulse oximetry and radial arterial duplex. The rate of radial artery blockage was essentially the same in both groups, with insignificant p-value=0.273. There was no statistically significant differences between the two agents in lowering of the radial occlusion rate when verapamil was used (65% had patent arteries with normal flow) or normal saline (60% had patent arteries with normal flow).
Conclusion: Verapamil might not be even required as a preventative measure during transradial treatments. Absence of verapamil might not only lower the drug-related problems, but also enable the safe application of transradial technique to patients who are verapamil-incompatible.
 
Keywords
Verapamil; Radial artery occlusion; Coronary angiography
Statistics
Article View: 242
PDF Download: 406